| Literature DB >> 25949871 |
Pravin Kesarwani1, Krishnamurthy Thyagarajan1, Shilpak Chatterjee1, Viswanathan Palanisamy2, Shikhar Mehrotra1.
Abstract
Improving persistence and sustained function of effector CD8+ T cell response is key for achieving significant tumor control in adoptive T cell immunotherapy protocols. Our recent report shows that high anti-oxidant property is central to potent anti-tumor effector T cells, and directly correlates to CD62Lhi central memory, low glycolytic and low mitochondrial membrane potential phenotype, all of which may be linked and contribute to better tumor control.Entities:
Keywords: adoptive immunotherapy, melanoma, Thiols, T cell
Year: 2015 PMID: 25949871 PMCID: PMC4368125 DOI: 10.4161/2162402X.2014.985942
Source DB: PubMed Journal: Oncoimmunology ISSN: 2162-4011 Impact factor: 8.110